🔥今日熱門話題: lly
|
香港
本頁為lly專題,實時追踨搜集關於lly的網上資料,全因2024年04月30日在香港引起了大量網友討論及關注。讀者可按自己興趣或需要,閱讀以下專題相關新聞或文章。
由於lly內容廣泛,應用場合多樣化,因此專題介紹並沒有特定的結構和風格。lly專題介紹是就某些特定的人物事物,或事物的某些特定的範圍、層面作比較專門、深入介紹的文字。一般專題介紹以面向社會公眾為主,通常沒有十分明確的寫作對象。
lly熱門新聞
透過以下網站快速搜尋「lly」
lly 關鍵字
其他網也最近也搜尋過關於lly的關鍵字
Warning: file_get_contents(aCache/Gkeys/hk/lly-2): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
lly相關新聞
-
美國藥企禮來(LLY)股價憑減肥藥Zepbound及Mounjaro令股價大升!投資前要考慮的4大因素 - Esquire HK
-
財報前瞻| 乘着減肥藥東風一路狂飆禮來(LLY.US)Q4業績還能驚豔市場嗎? 作者智通財經 - Investing.com 香港
-
傳禮來(LLY.US)對減肥藥新貴Viking(VKTX.US)的潛在收購已停滯 - 阿斯達克財經網
-
禮來(LLY.US)股價又雙叒叕創新高! 離“萬億美元俱樂部”越來越近作者智通財經 - Investing.com 香港
-
諾和諾德(NVO.US)和禮來(LLY.US)被嚇懵了!Viking(VKTX.US)減肥藥試驗取得積極結果,盤前暴漲逾88% - 阿斯達克財經網
-
禮來(LLY.US)將於週三完成對Point(PNT.US)14億美元收購作者智通財經 - Investing.com 香港
-
禮來(LLY.US)將啓動GLP-1R/GIPR/GCGR激動劑頭對頭司美格魯肽III期研究 - Investing.com 香港
-
市值破萬億的催化劑? 禮來(LLY.US)“減肥神藥”或於明年登陸印度 - 阿斯達克財經網
-
緩解供應不足非洲製藥商Aspen助力禮來(LLY.US)減肥藥生產作者智通財經 - Investing.com 香港
-
減肥神藥比電車更香!一夜蒸發800億美元后特斯拉(TSLA.US)市值被禮來(LLY.US)超越 - 阿斯達克財經網
-
禮來(LLY.US)巴瑞替尼新適應症國內獲批上市 - Investing.com 香港
-
耗資25億美元!禮來(LLY.US)新建德國工廠以促進肥胖症藥物供應 - Investing.com 香港
-
禮來(LLY.US)FGFR3抑制劑國內啓動臨牀 - Investing.com 香港
-
“減肥神藥”再迎利好!禮來(LLY.US)tirzepatide在治療睡眠障礙後期試驗取得積極結果作者智通財經 - Investing.com 香港
-
“減肥神藥”送貨上門!禮來(LLY.US)推出直購網站開拓肥胖藥市場新篇章 - Investing.com 香港
-
伯克希爾(BRK.A.US)和禮來(LLY.US)挑戰“七巨頭” 衝擊萬億美元市值俱樂部 - Investing.com 香港
-
最後時刻遇阻!禮來(LLY.US)阿爾茲海默症藥物突遭FDA推遲批准 - Investing.com 香港
-
禮來(LLY.US)再迎積極催化! 旗下溼疹藥物試驗顯示出顯著療效作者智通財經 - Investing.com 香港
-
強強聯合! 禮來(LLY.US)將攜手亞馬遜(AMZN.US)合作配送“減肥神藥” 作者智通財經 - Investing.com 香港
-
禮來(LLY.US)減肥藥效果優於諾和諾德(NVO.US) 後者盤前跌超2% - Investing.com 香港
-
上半年藥企股價哪家強?禮來(LLY.US)領跑美股同行提供者智通財經 - Investing.com 香港
-
禮來(LLY.US)口服GLP-1R激動劑在中國啓動3期臨床提供者智通財經 - Investing.com 香港
-
禮來(LLY.US)藥物Jardiance獲FDA批准用于治療慢性腎病 - Investing.com 香港
-
晨星公司:諾和諾德(NVO.US)、禮來(LLY.US)在減肥藥市場面臨日益激烈的競爭 - Investing.com 香港
-
【財報分析】簡評Eli Lilly and Company(LLY)最新的2023Q4業績|三苗 - 方格子 - 方格子
-
Is Eli Lilly Stock A Buy After Weight-Loss Win In Sleep Apnea? - Investor's Business Daily
-
What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday - Investopedia
-
Eli Lilly & Company (LLY) Should Continue Bullish Rally - The Globe and Mail
-
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies - Yahoo Finance
-
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
-
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance Australia
-
LLY and GOOG look great as the stock market tries to recover - London Loves Business
-
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
-
Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors - Yahoo Finance
-
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
-
LLY vs. JNJ: Which Big Pharma Stock Is Better? - TipRanks.com - TipRanks
-
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics - ca.finance.yahoo.com
-
Eli Lilly (LLY) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
-
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
-
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo Finance Australia
-
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
-
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
-
Eli Lilly and Company (NYSE:LLY) is largely controlled by institutional shareholders who own 84% of the company - Yahoo
-
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting - PR Newswire
-
Eli Lilly and Company (NYSE:LLY) Shares Up 1.5% - Defense World
-
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research
-
Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
-
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? - Zacks Investment Research
-
(LLY) Lilly Closer to Joining Magnificent Seven in $1 Trillion Market Cap Club - Bloomberg
-
LLY June 7th Options Begin Trading - Nasdaq
-
How To Trade (LLY) - Stock Traders Daily
-
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue - CNBC
-
Eli Lilly (LLY), Novo (NOVOB DC) Risk Missing High Expectations, Goldman Says - Bloomberg
-
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data - Yahoo Finance
-
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight - Yahoo Finance
-
Tesla (TSLA) Loses Its Luster as Weight Loss Drugmaker Lilly (LLY) Overtakes - Bloomberg
-
More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its ... - PR Newswire
-
Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
-
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans - TipRanks.com - TipRanks
-
What Makes Eli Lilly and Company (LLY) an Attractive Investment? - Yahoo Finance
-
Lilly (LLY) Partners Amazon to Deliver Drugs Like Zepbound - Yahoo Finance
-
Eli Lilly and Co (LLY) Reports 28% Revenue Surge in Q4 2023, Forecasts Continued Growth - Yahoo Finance
-
Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards? - Yahoo Finance
-
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts - Zacks Investment Research
-
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma - PR Newswire
-
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
-
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Yahoo Finance Australia
-
Berkshire and Lilly Race to Shake Tech's Grip on Trillion-Dollar Club - Bloomberg
-
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S - Simply Wall St
-
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
-
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts - Yahoo
-
Eli Lilly and Company (NYSE:LLY) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
-
LLY Stock Alert: You Can Now Get Eli Lilly's Weight Loss Drugs on Amazon - InvestorPlace
-
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
-
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies - ca.finance.yahoo.com
-
LLY, CVS, EXAS: Which Strong-Buy-Rated Healthcare Stock Is the Better Buy? - Yahoo Finance
-
#5. Lilly(Eli) & Co (LLY) | State | pdclarion.com - Princeton Clarion
-
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Yahoo Finance
-
Eli Lilly and Company (LLY) to Release Quarterly Earnings on Tuesday - Defense World
-
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023 - PR Newswire
-
Lilly (LLY) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
-
Lilly Completes Acquisition of POINT Biopharma - PR Newswire
-
Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and more - CNBC
-
Eli Lilly Shares Show Healthy Rise - Yahoo Finance Australia
-
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More - Yahoo Finance
-
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
-
Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma - PR Newswire
-
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month - TipRanks.com - TipRanks
-
LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer? - Yahoo Finance
-
LLY Should Provide Opportunity In Few Weeks - The Globe and Mail
-
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™ - PR Newswire
-
How to Buy Eli Lilly Stock (LLY) - The Motley Fool
-
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts - Zacks Investment Research
-
Eli Lilly and Company (NYSE:LLY) Q4 2023 Earnings Call Transcript - Yahoo Finance
-
Should You Pick Eli Lilly Stock After A 4x Rise In Three Years? - Forbes
-
Eli Lilly (LLY), Novartis (NOVN SW) Focus on Smaller Acquisitions - Bloomberg
-
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook - CNBC
-
Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance | Eli ... - Eli Lilly and Company
更多lly相關網站:
關於lly
Warning: file_get_contents(aCache/search/hk/lly): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
Back to Top